About Accolade Inc
Ticker
info
ACCD
Trading on
info
NASDAQ
ISIN
info
US00437E1029
Industry
info
Health Information Services
Sector
info
Healthcare
CEO
info
Rajeev Singh
Headquarters
info
1201 Third Avenue, Seattle, WA, United States, 98101
Employees
info
2,400
Website
info
accolade.com
Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialists, expert medical opinion providers, and primary care physicians. It also provides medical opinion services to commercial customers; and navigation, care, and advocacy solutions. In addition, the company offers medical consultations that connect patients to qualified condition-specific specialists for adult and pediatric care; and primary care and mental health support solutions. It serves employers who provide employees and their families a single place to turn for their health, healthcare, and benefits needs. The company was incorporated in 2007 and is headquartered in Seattle, Washington.
Metrics
BasicAdvanced
Market cap
info
$576M
P/E ratio
info
-
EPS
info
-$2.28
Dividend Yield
info
0.00%
Beta
info
2.1
Forward P/E ratio
info
0
EBIDTA
info
$-47.6M
Ex dividend date
info
-
Price & volume
Market cap
info
$576M
Average daily volume
info
1.1M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
1.29
Price to book
info
1.84
Earnings
EPS
info
-$2.28
EPS estimate (current quarter)
info
-$0.16
EPS estimate (next quarter)
info
$0.00
EBITDA
info
$-47.6M
Revenues (TTM)
info
$447M
Revenues per share (TTM)
info
$5.72
Technicals
Beta
info
2.1
52-week High
info
$9.41
52-week Low
info
$3.08
50-day moving average
info
$6.95
200-day moving average
info
$4.77
Short ratio
info
1.52
Short %
info
2.55%
Management effectiveness
ROE (TTM)
info
48.23%
ROA (TTM)
info
7.50%
Profit margin
info
40.36%
Gross profit margin
info
$215M
Operating margin
info
22.71%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
5.70%
Share stats
Outstanding Shares
info
82M
Float
info
63.9M
Insiders %
info
3.28%
Institutions %
info
88.19%
Analyst Insights & forecasts
info

25% Buy

75% Hold

0% Sell

Based on information from 12 analysts.

Average price target

info
$7.03
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.10
-$0.07
42.86%
Q1 • 24Beat
-$0.35
-$0.48
27.08%
Q2 • 24Beat
-$0.30
-$0.44
31.82%
Q3 • 24Beat
-$0.16
-$0.32
50.56%
Q4 • 24Beat
-
-
-
Q1 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$106M
$-23.9M
22.50%
Q3 • 24
$105M
$-121M
115.42%
Q4 • 24
1.22%
406.66%
412.92%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$756M
$333M
44.04%
Q3 • 24
$647M
$334M
51.66%
Q4 • 24
14.37%
0.44%
17.29%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$4.1M
$-19.5M
$0M
$3.1M
Q3 • 24
$-9.7M
$21.2M
$1.1M
$-7.8M
Q4 • 24
334.89%
208.46%
10,245.45%
350.95%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Accolade Inc share?
Collapse

Accolade Inc shares are currently traded for undefined per share.

How many shares does Accolade Inc have?
Collapse

Accolade Inc currently has 82M shares.

Does Accolade Inc pay dividends?
Collapse

No, Accolade Inc doesn't pay dividends.

What is Accolade Inc 52 week high?
Collapse

Accolade Inc 52 week high is $9.41.

What is Accolade Inc 52 week low?
Collapse

Accolade Inc 52 week low is $3.08.

What is the 200-day moving average of Accolade Inc?
Collapse

Accolade Inc 200-day moving average is $4.77.

Who is Accolade Inc CEO?
Collapse

The CEO of Accolade Inc is Rajeev Singh.

How many employees Accolade Inc has?
Collapse

Accolade Inc has 2,400 employees.

What is the market cap of Accolade Inc?
Collapse

The market cap of Accolade Inc is $576M.

What is the P/E of Accolade Inc?
Collapse

The current P/E of Accolade Inc is null.

What is the EPS of Accolade Inc?
Collapse

The EPS of Accolade Inc is -$2.28.

What is the PEG Ratio of Accolade Inc?
Collapse

The PEG Ratio of Accolade Inc is null.

What do analysts say about Accolade Inc?
Collapse

According to the analysts Accolade Inc is considered a hold.